Does DENOSUMAB Cause Therapy non-responder? 347 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 347 reports of Therapy non-responder have been filed in association with DENOSUMAB (Bilprevda). This represents 0.2% of all adverse event reports for DENOSUMAB.
347
Reports of Therapy non-responder with DENOSUMAB
0.2%
of all DENOSUMAB reports
15
Deaths
27
Hospitalizations
How Dangerous Is Therapy non-responder From DENOSUMAB?
Of the 347 reports, 15 (4.3%) resulted in death, 27 (7.8%) required hospitalization, and 5 (1.4%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 347 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which DENOSUMAB Alternatives Have Lower Therapy non-responder Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE